Vuno Inc. (338220)
Market Open
11 Aug, 06:30
KRX SM KRX SM Primary ₩
8,460. 00
-20
-0.2358%
₩
313.64B Market Cap
- P/E Ratio
- Div Yield
1,585 Volume
- Eps
₩ 8,480
Previous Close Want to track 338220 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
338220 trading today lower at ₩8,460, a decrease of -0.2358% from yesterday's close, completing a monthly increase of 5.0932% or ₩410. Over the past 12 months, 338220 stock lost -62.4%.
338220 is not paying dividends to its shareholders.
The last earnings report, released on Feb 04, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
338220 Chart
Vuno Inc. (338220) FAQ
What is the stock price today?
The current price is ₩8,460.00.
On which exchange is it traded?
Vuno Inc. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 338220.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 313.64B.
Has Vuno Inc. ever had a stock split?
No, there has never been a stock split.
Vuno Inc. Profile
| Insurance Industry | Financials Sector | - CEO | KRX SM Exchange | KR7338220007 ISIN |
| South Korea Country | 150 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Vuno Inc. is a leading innovator in the medical artificial intelligence (AI) sector, dedicated to the development of cutting-edge AI solutions aimed at revolutionizing the way medical data is analyzed and used in the diagnosis of diseases. Established in 2014 and headquartered in Seoul, South Korea, Vuno has emerged as a pioneer in the integration of artificial intelligence with healthcare, providing technologies that enhance the accuracy, speed, and efficiency of medical diagnostics. Through its advanced AI software, Vuno is addressing the critical needs of healthcare professionals and patients, offering tools that facilitate better decision-making and improving patient outcomes.
Products and Services
- BoneAge - An innovative AI diagnostic software specifically designed for assessing bone age. This tool utilizes advanced AI algorithms to analyze X-ray images, providing accurate and rapid assessments. It is particularly useful in pediatric healthcare, assisting in the evaluation of developmental disorders and growth anomalies.
- DeepBrain - A cutting-edge brain parcellation AI technology that offers quantitative analysis tools for neurodegenerative diseases and various neurological disorders. DeepBrain aids in the detailed mapping and evaluation of brain structures, enhancing the diagnostic process for conditions such as Alzheimer's disease, Parkinson's disease, and other cognitive impairments.
- Chest X-ray - A diagnostic support system that leverages AI to detect abnormalities within chest X-rays. This software streamlines the identification process of numerous chest-related conditions, offering a robust tool for the early detection and management of pulmonary diseases.
- Fundus AI - An AI-based screening solution designed for the detection of abnormalities in the fundus of the eye. Fundus AI plays a crucial role in the early diagnosis and treatment planning of various ocular conditions, including diabetic retinopathy, glaucoma, and age-related macular degeneration, among others.
- LungCT AI - A comprehensive AI-based pulmonary lung nodule detection and reporting system. LungCT AI excels in identifying and reporting on lung nodules, exploiting sophisticated AI algorithms to enhance the accuracy of lung cancer screenings and facilitate timely interventions.
Contact Information
Address: 479, Gangnam-daero
Phone: 82 2 515 6646
Website: https://www.vuno.co
